Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.
Nakagami
Taku
T
Yasui-Furukori
Norio
N
Saito
Manabu
M
Mihara
Kazuo
K
De Vries
Ronald
R
Kondo
Tsuyoshi
T
Kaneko
Sunao
S
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001711:Biotransformation; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism; D004347:Drug Interactions; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D018967:Risperidone / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics; D013881:Thioridazine / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D019389:Cytochrome P-450 CYP2D6; D018967:Risperidone; D013881:Thioridazine